Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.868
-0.022 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.870
+0.002 (0.23%)
After-hours: Apr 28, 2026, 7:57 PM EDT
RANI Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RANI stock have an average target of 7.50, with a low estimate of 4.00 and a high estimate of 11. The average target predicts an increase of 764.06% from the current stock price of 0.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RANI stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +476.04% | Apr 1, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,167.28% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,167.28% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +1,167.28% | Oct 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +1,052.07% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
6.12M
from 1.63M
Increased by 274.77%
Revenue Next Year
10.98M
from 6.12M
Increased by 79.44%
EPS This Year
-0.21
from -0.45
EPS Next Year
-0.20
from -0.21
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 18.9M | 18.9M | ||||||
| Avg | 6.1M | 11.0M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1,057.4% | 208.8% | ||||||
| Avg | 274.8% | 79.4% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.14 | -0.19 | ||||||
| Avg | -0.21 | -0.20 | ||||||
| Low | -0.29 | -0.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.